ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NVO Novo Nordisk

121.76
-1.29 (-1.05%)
Pre Market
Last Updated: 14:15:43
Delayed by 15 minutes
Share Name Share Symbol Market Type
Novo Nordisk NYSE:NVO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -1.29 -1.05% 121.76 95,294 14:15:43

ADRs Mostly Gain in New York Trading; Gold Producers Trade Actively

25/06/2019 12:04am

Dow Jones News


Novo Nordisk (NYSE:NVO)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novo Nordisk Charts.

By Micah Maidenberg

 

International stocks trading in New York mostly recorded gains on Monday.

The S&P/BNY Mellon index of American depositary receipts ticked up 0.1% to 141.76. The European index rose 0.09% to 132.63. The Asian index was unchanged at 161.70 and the Latin American index was up 0.6%, closing at 249.75. The emerging markets index increased 0.1% to close at 304.25

The ADRs for gold producers traded actively on Monday. Barrick Gold Corp.'s (GOLD) ADR rose 4% to close at $16.24, while Gold Fields Ltd.'s (GFI) ADR gained 5% to close at $5.62. The ADR for Harmony Gold Co. (HMY) was up about 3%, closing at $2.24, while AngloGold Ashanti Ltd. (AU) saw its ADR rise 4% to $17.76.

Last week, gold futures closed at a four-year high. Prices for gold, along with other metals, have been rising as investors sort through a range of economic risks, including recent tensions between Iran and the U.S., as well as the prospect that central banks will lower interest rates to support growth.

The ADR for Novo Nordisk (NVO) also traded actively. Earlier in the day, the Danish pharmaceutical company issued a statement detailing progress on a share buyback program worth $2.28 billion assuming today's exchange rate between the Danish krone and the dollar. The company said it had, through June 21, bought more than 3.8 million shares in its B-class of stock. Shares rose about 1% to $51.29.

 

Write to Micah Maidenberg at Micah.Maidenberg@WSJ.com

 

(END) Dow Jones Newswires

June 24, 2019 18:49 ET (22:49 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Novo Nordisk Chart

1 Year Novo Nordisk Chart

1 Month Novo Nordisk Chart

1 Month Novo Nordisk Chart

Your Recent History

Delayed Upgrade Clock